Withings

Explainers

Plain-language answers to the questions people ask about Withings, from DEPLOY’s explainer library. Each is written in the language of the question and cross-checked against this registry.

• What is Withings ScanWatch?

  Withings is an independent French biometric wearable company; the ScanWatch line (ScanWatch + ScanWatch 2 + ScanWatch Nova) is the cohort's hybrid analog watch archetype. ECG cleared 2021 EU / OTC 2025 US; SpO2 monitoring across the line. Founded as Withings in France; acquired by Nokia 2016; bought back by founder Eric Carreel 2018; currently independent. Per DEPLOY's biometric cluster framework, Withings anchors the substantial-cleared-for-size archetype: hybrid mechanical-digital design distinct in cohort with cohort-mature peer-reviewed validation depth.

• How does DEPLOY track the Withings ScanWatch ECG recall?

  The Withings ScanWatch FDA Class-2 recall operates as a canonical worked example of incident-tracking at FDA medical-device primary-source verification depth. Per Agent A IncidentStatusEvent substrate at [/incidents/withings-scanwatch-ecg-recall-2022](https://registry.deploy.report/incidents/withings-scanwatch-ecg-recall-2022): the U.S. Food and Drug Administration (FDA) issued a Class-2 recall on the Withings ScanWatch ECG feature in 2022. The recall operates at FDA medical-device primary-source verification depth (tier 2 primary-FDA-database per [DEPLOY's 9-tier source-quality rubric](/explainers/source-quality-rubric)); the recall sub-tier is structurally distinct from the CPSC consumer-product-safety sub-tier exercised in the [Fitbit Ionic burn recall narrative](/explainers/how-deploy-tracks-the-fitbit-ionic-burn-recall). CRITICAL within-entity verification-state framing: the ScanWatch is a multi-feature device with FDA-cleared ECG + SpO2 (K201456) intersecting with the regulatory recall framing; per [verified-vs-claimed at within-entity granularity](/explainers/verified-vs-claimed-within-entity), the recall affects the ECG feature specifically while other ScanWatch features remained available; the broader [Withings entity](/explainers/what-is-withings) continues at verified-shipped state across the ScanWatch + ScanWatch 2 + ScanWatch Nova product line. Per [DEPLOY's biometric cluster framework](/explainers/biometric), the recall operates within the hybrid analog watch archetype that Withings anchors. This piece documents the catch as framework-in-action worked example: FDA medical-device incident-tracking discipline + within-entity feature-granularity verification-state distribution + multi-tier primary-government-record source-quality demonstration operating at editorial-anchor depth.

Current leadership (2)

• Mathieu Letombe CEOsecondary-verified
• Eric Carreel Co-founder & Chairmansecondary-verified

Founders (3)

• Eric Carreelcofounderfounded 2008-01-01
• Cedric Hutchingscofounderfounded 2008-01-01no longer at company
• Fred Pottercofounderfounded 2008-01-01no longer at company

Board (1)

• Eric Carreel chair

Former / Previously (2)

• Cedric Hutchings Co-founder & former CEOsecondary-verified
• Fred Potter Co-founder & former CTOsecondary-verified

Safety record

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Incidents affecting Withings (1)

• Withings ScanWatch FDA Class 2 recall: app bug let users run ECG without physician review2022-12-19 · Recall

Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Operated deployments (1)

• Withings ScanWatchGlobal

Operator customers (1)

• Withings1 deployment

Peer companies

• Samsung Electronics4 models
• Butterfly Network2 models
• Abbott1 model
• Apple1 model
• Circular1 model
• Dexcom1 model

Financial state

Reporting basis

private_reported

Lifecycle stage

mature

Counterparty risk class

low

Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.

Funding rounds (1)

• Series B2026-07-08

  $30M(reported)

Regulatory filings (1)

• K201456fda 510k · us_fdacleared2020-06-01

  Linked models: Withings ScanWatch

Sources (4)

1. https://en.wikipedia.org/wiki/Withings ↗
2. https://support.withings.com/hc/en-us/articles/16780197080209-ScanWatch-2-ECG-Frequently-Asked-Questions-FAQ-U-S-Only ↗
3. https://support.withings.com/hc/en-us/articles/36773695647249-ScanWatch-2-ECG-Update-2025-U-S ↗
4. https://sleepreviewmag.com/sleep-diagnostics/consumer-sleep-tracking/wearable-sleep-trackers/fda-clears-withings-scanwatch-spo2/ ↗

Common questions

What is Withings?

French consumer-health-electronics company (Issy-les-Moulineaux; founded 2008; independent since 2018) of the ScanWatch hybrid analog smartwatches with FDA-cleared ECG/AFib + SpO2.

What does Withings make?

Withings has 1 robot model on the DEPLOY registry: Withings ScanWatch (Withings builds both physical robots and the AI that runs them).

Is Withings publicly traded?

No. Withings is privately held and not publicly traded, per the DEPLOY registry.

Who competes with Withings?

On the DEPLOY registry, peer companies to Withings building in the same form factors include Samsung Electronics, Butterfly Network, Abbott, Apple.

Where is Withings headquartered?

Withings is headquartered in Issy-les-Moulineaux, France.